A Brief Review On Cleaning Validation-Regulatory Guidelines For Pharmaceuticals

Abstract

Cleaning validation is a process used by pharmaceutical manufacturers to ensure that their equipment and facilities are thoroughly cleaned and free of any residual contaminants that could potentially compromise the quality of their products. This process is guided by regulatory guidelines set forth by FDA and European Medicines Agency (EMA) are two examples of such agencies.

Cleaning validation protocols are typically required by these guidelines, which outline cleaning procedures, acceptance criteria for evaluating the effectiveness, as well as testing and documenting the results. The protocol should also include a risk assessment to determine which equipment and areas of the facility are most critical to the product's quality and safety.

Manufacturers are also expected to periodically review and update their cleaning validation protocols as necessary, and to keep detailed records of all cleaning validation activities. A manufacturer's cleaning validation protocol and the presence of contaminants may also be verified by FDA or EMA inspections. To ensure consistently high quality, pharmaceutical manufacturers must control cross-contamination. There must be a comprehensive cleaning regime in place to demonstrate that the methods employed in a facility consistently control the carryover of product (including intermediates and impurities), cleaning agents, and extraneous material into subsequent products. An effective cleaning regime provides documented evidence that these aspects are consistently controlled within a facility. As a pharmaceutical manufacturer, it is your responsibility to ensure that your cleaning process complies with cGMP regulations, first and foremost.